Health-care companies rose as a reported U.S. death from bird flu stoked fears of a new pandemic, boosting shares of vaccine makers.
Moderna rose by more than 12%, while Novavax and CureVac also rallied after U.S. health officials confirmed the first American death caused by the H5N1 bird flu in Louisiana. The latest weekly tally of Covid-19 cases also rose sharply.
Novo Nordisk shares fell after President-elect Donald Trump vowed to "tariff Denmark at a very high level" if the nation refused to hand sovereignty over Greenland to the U.S.
WuXi Biologics agreed to sell an overseas vaccine facility to Merck for $500 million, a move that could strengthen the Chinese drugmaker's cash flow and margins as it navigates global uncertainties.
MAIA Biotechnology's shares rallied after the biotech firm struck a deal with BeiGene to explore development of a telomere-targeting anticancer agent. A telomere is a chromosome feature thought to play a role in cancer and aging, among other things.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
January 07, 2025 17:59 ET (22:59 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。